Format

Send to

Choose Destination
Endocrinol Metab Clin North Am. 2010 Sep;39(3):513-25. doi: 10.1016/j.ecl.2010.05.007.

Advances in the prediction and natural history of type 1 diabetes.

Author information

1
Deutsche Forschungsgemeinschaft Center for Regenerative Therapies Dresden, Technische Universit├Ąt Dresden, Tatzberg 47/49, 01307 Dresden, Germany. ezio.bonifacio@crt-dresden.de

Abstract

Type 1 diabetes (T1D) has the hallmark characteristics of autoimmunity superimposed on genetic susceptibility. Both genes (HLA) and immune markers (autoantibodies) have been validated as predictive markers of the subsequent development of the disease in higher-risk relatives and the lower-risk general population. Over the last three decades, using a combination of genes, immune, and metabolic markers, clinicians are now able to quantify an individual's disease risk from 1 in 100,000 to more than 1 in 2. This article reviews these biomarkers and T1D prediction strategies, and discusses potential implications of prediction and natural history for the pathogenesis of T1D.

PMID:
20723817
DOI:
10.1016/j.ecl.2010.05.007
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center